224 related articles for article (PubMed ID: 11082391)
1. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy.
Caforio AL; Fortina AB; Piaserico S; Alaibac M; Tona F; Feltrin G; Pompei E; Testolin L; Gambino A; Volta SD; Thiene G; Casarotto D; Peserico A
Circulation; 2000 Nov; 102(19 Suppl 3):III222-7. PubMed ID: 11082391
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
3. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
4. Skin cancer in heart transplant recipients: frequency and risk factor analysis.
Fortina AB; Caforio AL; Piaserico S; Alaibac M; Tona F; Feltrin G; Livi U; Peserico A
J Heart Lung Transplant; 2000 Mar; 19(3):249-55. PubMed ID: 10713249
[TBL] [Abstract][Full Text] [Related]
5. Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy.
Felkel TO; Smith AL; Reichenspurner HC; LaFleur B; Lutz JF; Kanter KR; Gravanis MB; Johnston TS
J Heart Lung Transplant; 2002 May; 21(5):530-9. PubMed ID: 11983542
[TBL] [Abstract][Full Text] [Related]
6. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
[TBL] [Abstract][Full Text] [Related]
7. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?
Gjersvik P; Hansen S; Møller B; Leivestad T; Geiran O; Simonsen S; Pfeffer P; Fauchald P
Transpl Int; 2000; 13 Suppl 1():S380-1. PubMed ID: 11112037
[TBL] [Abstract][Full Text] [Related]
8. Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression.
Olivari MT; Diekmann RA; Kubo SH; Braunlin E; Jamieson SW; Ring WS
J Heart Transplant; 1990; 9(6):618-21. PubMed ID: 2277297
[TBL] [Abstract][Full Text] [Related]
9. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.
Jensen P; Hansen S; Møller B; Leivestad T; Pfeffer P; Geiran O; Fauchald P; Simonsen S
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):177-86. PubMed ID: 10025742
[TBL] [Abstract][Full Text] [Related]
10. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous manifestations of renal transplantation in a New Zealand population.
Hepburn DJ; Divakar D; Bailey RR; Macdonald KJ
N Z Med J; 1994 Dec; 107(991):497-9. PubMed ID: 7830977
[TBL] [Abstract][Full Text] [Related]
12. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.
Funk-Debleds P; Ducroux E; Guillaud O; Ursic-Bedoya J; Decullier E; Vallin M; Euvrard S; Pageaux GP; Boillot O; Dumortier J
J Am Acad Dermatol; 2018 Jul; 79(1):84-91. PubMed ID: 29307647
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
[TBL] [Abstract][Full Text] [Related]
14. Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen.
Nohria A; Ehtisham J; Ramahi TM
J Heart Lung Transplant; 1998 Sep; 17(9):849-53. PubMed ID: 9773855
[TBL] [Abstract][Full Text] [Related]
15. Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients.
Oliveira WRP; Tirico MCCP; Souza AAV; Codarin FR; Silva LLC; Festa Neto C
Int J Dermatol; 2019 Apr; 58(4):440-448. PubMed ID: 30565651
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients.
Glover MT; Deeks JJ; Raftery MJ; Cunningham J; Leigh IM
Lancet; 1997 Feb; 349(9049):398. PubMed ID: 9033469
[No Abstract] [Full Text] [Related]
17. Identification of patients not requiring endomyocardial biopsies late after cardiac transplantation.
Brunner-La Rocca HP; Kiowski W
Transplantation; 1998 Feb; 65(4):533-8. PubMed ID: 9500629
[TBL] [Abstract][Full Text] [Related]
18. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.
Rivinius R; Helmschrott M; Ruhparwar A; Schmack B; Klein B; Erbel C; Gleissner CA; Akhavanpoor M; Frankenstein L; Darche FF; Thomas D; Ehlermann P; Bruckner T; Katus HA; Doesch AO
Drug Des Devel Ther; 2015; 9():93-102. PubMed ID: 25552900
[TBL] [Abstract][Full Text] [Related]
19. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
20. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma.
Euvrard S; Kanitakis J; Decullier E; Butnaru AC; Lefrançois N; Boissonnat P; Sebbag L; Garnier JL; Pouteil-Noble C; Cahen R; Morelon E; Touraine JL; Claudy A; Chapuis F
Transplantation; 2006 Apr; 81(8):1093-100. PubMed ID: 16641592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]